Advice
in the absence of a submission from the holder of the marketing authorisation:
bilastine (Ilaxten®) is not recommended for use within NHS Scotland.
Indication under review: symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice38KB (PDF)
Medicine details
- Medicine name:
- bilastine (Ilaxten®)
- SMC ID:
- 730/11
- Indication:
- Symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria
- Pharmaceutical company
- A Menarini Pharmaceuticals UK Ltd
- BNF chapter
- Respiratory system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 August 2011